Background. Age-related loss of muscle mass and function (sarcopenia) is linked to poor outcomes after operation and trauma. Here we evaluate computed tomography measured psoas muscle density and area using quick and simple tools available to the bedside clinician. We hypothesize these measures will predict poor outcomes after blunt traumatic injury. Methods. We conducted a retrospective cohort study of patients ages $45 years in the Ohio State University Trauma Registry in 2008 that received a computed tomographic scan of the abdomen and/or pelvis with intravenous contrast. Psoas Index and Hounsfield unit average calculation were measured at the L3 level. In the study, 90-day mortality, complication, duration of stay $7 days, and dependent discharge were compared with Psoas Index and Hounsfield unit average calculation. Results. In the study, 151 patients met the inclusion criteria. Patients were stratified into interquartile ranges based either on Psoas Index or Hounsfield unit average calculation values. After adjustment with sex-specific cutoffs, the lowest interquartile range of Psoas Index was associated with 90-day mortality (relative risk [RR] 5.95, P < .008), but did not reach significance in other outcomes. The lowest interquartile range of Hounsfield unit average calculation was associated with 90-day mortality (RR 5.95, P < .008), duration of stay $ 7 days (RR 1.63, P = .048), complication risk (RR 2.30, P = .002), and dependent discharge 2.14, P = .015). Conclusion. Psoas muscle density is a significant predictor of poor outcomes after traumatic injury. This objective, quick, and readily available measure of sarcopenia can identify patients requiring aggressive nutritional and physical therapy to improve prognosis, prevent recurrent traumatic injury, and aid in discharge planning. (Surgery 2017;162:377-84.) 
The pathologic manifestation of sarcopenia, known as the frailty syndrome, describes the general decline in physiologic reserve associated with loss of muscle mass and function that leaves the patient recursively vulnerable to disease and wasting. 3, 4 Previous studies have shown that frailty is associated strongly with poor operative and post-traumatic outcomes. [4] [5] [6] However, an objective assessment of physiologic reserve to measure frailty has not yet been standardized. Many approaches rely on combining data from the patient's past medical history with functional and mental status assessments to create a composite risk score. [4] [5] [6] [7] Unfortunately, these measures are time consuming and are reliant on the completeness of the medical record and quality of subjective data that often are not available in the emergent traumatic or operative setting.
Thus, several groups have proposed using direct imaging measures of sarcopenia as an objective and easy to measure marker of physiologic reserve. [8] [9] [10] [11] [12] [13] Several studies have validated the computed tomography (CT) psoas muscle measurements at the L3 vertebral level as a predictor of poor outcomes in multiple settings including liver transplantation, and oncologic operation. [8] [9] [10] [11] [12] [13] In addition, recent studies have found that CT psoas density, which focuses on measuring muscle quality and degree of age-related fatty muscular infiltration rather than gross mass, can be used to predict mortality in gastrointestinal oncologic operation. 10, 12 Like major operation, traumatic injury represents a significant physiologic insult from which frail patients have a limited capacity to recover. Thus, evaluating frailty in the emergent traumatic setting would be a valuable tool in identifying patients at increased risk of poor outcomes that may benefit from specific physical and nutritional regimens to mitigate risk and improve physiologic reserve from future traumatic events. CT psoas based measurements of sarcopenia in trauma are attractive due to the ubiquitous use of CT scans in evaluating traumatic injuries and the simplicity and speed of measurement. The objective of this study is to evaluate CT-based psoas muscle area and density as prognostic markers for poor outcomes in blunt traumatic injury.
METHODS
Data source and patient characteristics. We reviewed the Ohio State University Trauma Registry for patients aged $45 years with blunt mechanism of trauma that underwent evaluation between January 1, 2008 and December 31, 2008 with CT abdomen/pelvis with venous contrast during the initial trauma evaluation. For each patient record, detailed clinical variables were collected including age, sex, body mass index (BMI), independent status before trauma, mechanism of trauma, presenting Glasgow Coma Scale Score, Injury Severity Score, number of injuries sustained, number of medications, and number of comorbidities.
Outcome data collected included 90-day mortality (from the Social Security Death Index), risk of complication, discharge to a dependent facility (long-term acute care hospital or skilled nursing facility), and duration of stay $7 days.
CT image analysis and sarcopenia calculation. The right and left psoas muscles were traced at the L3 level with EasyViz PACS (Picture Archiving and Communications System) imaging software (Karos Health, Waterloo, ON; Fig 1) . EasyViz is an "ultra-thin" Web-based PACS client installed enterprise-wide that is easily accessible to bedside clinicians. The psoas index (PI) was measured by summing the right psoas muscle area (RPA) and left psoas area (LPA), to obtain the total psoas area (TPA) then normalizing by the square of the height: PI = (RPA + LPA)/height 2 in cm 2 / m 2 . 13 Psoas density was measured as the Hounsfield unit average calculation and was determined by summing the product of the right mean psoas Hounsfield unit density and RPA with that of the product of the left mean psoas Hounsfield unit density and LPA, then dividing by the TPA: Hounsfield unit average calculation (HUAC) = [(right mean psoas Hounsfield unit density 3 RPA) + (left mean psoas Hounsfield unit density 3 LPA)]/(TPA) in Hounsfield units. 10, 12 Patients were stratified based on the interquartile range (IQR) for our measures of sarcopenia into 4 groups where IQR1 corresponded to the lowest 25th percentile of values to IQR4, which corresponded to the highest 25th percentile of values. To adjust for sex-specific differences in psoas area, we separated our patients into quartiles with sex-specific cutoffs, thereby defining the lowest 25th percentile of men and the lowest 25th percentile of women as sarcopenic. Our sarcopenia cutoff for HUAC was the lowest 25th percentile value (HUAC value of 38.5 HU).
Statistical analysis. 
RESULTS
Baseline patient characteristics. We stratified patients into interquartile ranges based on either their psoas area or psoas density (Supplementary Table I ). Our muscle density cutoff for sarcopenia was defined as the 25th percentile value of HUAC (sarcopenia by HUAC #38.5 HU). Given the significant sex-specific difference in PI, our muscle size specific cutoff was defined as the 25th percentile value of PI by sex (sarcopenia by PI, male #7.77 cm 2 /m 2 , female #4.75 cm 2 /m 2 ). We categorized complications by a set list (Supplementary  Table II) .
In the study, 151 patients met our study criteria. Patient characteristics (Table I) included mean age 58.8 years, 60.9% male, BMI 28.3, home independence before trauma 89.4%, mean ISS 10.4, Glasgow Coma Scale 13.4, mechanism of fall 22.5%, number of injuries from trauma of 4.7, mean number of home medications 3.7, and pretrauma comorbidities 2.9.
Psoas density versus psoas area as a marker of frailty. When we stratified patients by psoas density, we found that the sarcopenic group had significant covariates that we would expect to find with frailty. Patients were significantly older (Table I , mean age 65.6 vs 56.5 years, P < .001), took more home medications (Table I, 5.2 vs 3.2, P < .01), and had more comorbidities (Table I, 4.6 vs 2.3, P < .001). There was also a significant increase in trauma caused by falls (34.2% vs 17.8%, P < .05) and BMI (30.4 vs 27.6, P < .03).
Initial analysis comparing sarcopenia by sexadjusted PI found significant differences between men and women (Fig 2, A, 9 .01 vs 5.95 cm 2 /m 2 , P < .001). In contrast, average psoas density HUAC values between men and women, there was no sex-specific difference (Fig 2, B, 43.6 vs 42.7 HU, P = .46). For our covariate analysis, after sex-specific adjustment of PI, the sarcopenic group remained significantly older (Table I, mean age 62.2 vs 57.6 years, P < .03); however, other covariates associated with frailty were not significant.
To validate psoas density as a marker of frailty, we tested it against other covariates of frailty, including age, number of medications, and number of comorbidities. We found that psoas density was correlated negatively with these other markers of frailty (Fig 3, A, age vs HUAC r = À0.37, P < .001; Fig 3, B , number of comorbidities vs HUAC r = À0.41, P < .001; Fig 3, C, number of medications vs HUAC r = À0.33, P < .001), indicating that as muscle density decreases, patients tend to be older, with increasing comorbidities and medication use. In comparison, PI was significantly correlated with older age in women (Fig 4, A, r = À0.41, P = .002), but not in men (Fig 4, A .50 r = À0.18, P = .08), or our other markers of frailty for both sexes (Fig 4, B, women r = À0.14, P = .30, men r = 0.04, P = .74; Fig 4, C, women r = À0.10, P = .44, men r = 0.12, P = .24). Our results suggest that psoas density covaries with multiple markers of frailty in contrast to psoas area, making density a better overall marker of frailty.
Outcomes by psoas density and psoas area measured sarcopenia. In terms of our cohort outcomes, (Table II) the 90-day mortality was 6.0%. The average duration of stay was 7.2 days with 31.7% of our cohort staying $7 days. The overall complication rate was 25.8%. After excluding our inpatient deaths, our dependent discharge to a skilled nursing facility or long-term acute care hospital rate was 21.8%.
Patients with sarcopenia by HUAC had significantly increased probability of 90-day mortality (Table II, (Table II, 15 .8% vs 2.7%, P = .008), but no increased risk in our other outcome measures. When our cohort is grouped into quartiles by psoas density, there seemed to be a densitydependent effect. As psoas density decreases, the probability of 90-day mortality, duration of stay $7 days, increased complication rate, and dependent discharge increased (Fig 5, A) . This effect was only noticeable with 90-day mortality when stratifying by sex-adjusted PI (Fig 5, B) .
In terms of relative risk, patients with sarcopenia by HUAC had increased 90-day mortality (Table III, relative risk [RR] 5.95, P = .008), duration of stay $7 days (Table III, RR 1.63, P = .048), complication risk (Table III, RR 2 .30, P = .002), and dependent discharge (Table III, 2. 14, P = .015). Patients with sarcopenia by PI had increased relative risk of 90-day mortality (RR 5.95, P = .008), but failed to reach significance in other outcomes. Taken together, our data show that psoas density is a significant predictor of multiple poor outcomes after trauma and is therefore a better predictor of poor outcomes compared with psoas area.
DISCUSSION
Frailty is recognized as a significant contributor to age-related morbidity and mortality. However, there remains no standardized definition or method to identify the representative pathologic loss of physiologic reserve. Current methods often rely on measures in the patient history and functional tests that are reliant on patient effort.
The subjective nature and variability of these metrics, as well as the time-consuming nature in gathering them may limit their clinical utility. [4] [5] [6] [7] Therefore, there is significant interest in assessing sarcopenia with faster, objective measurements. In operation and trauma, there is a growing body of literature showing that CT-based muscle measurements predict complications and mortality, with CT psoas area and density becoming increasingly utilized. [8] [9] [10] [11] [12] [13] [14] In contrast to previous studies, we directly compare CT psoas area to density in predicting poor outcomes after blunt trauma. We find that psoas density is an overall better predictive marker of outcomes for several reasons. Psoas density was significantly associated with more covariates of frailty, including age, number of comorbidities, and number of medications. Density predicted multiple poor outcomes, including mortality, inpatient duration of stay, complications, and dependent discharge as compared with psoas area, which significantly predicted mortality after normalizing for height and sex, but not our other outcome measures. Interestingly, we found a trend in which decreasing psoas density increased the likelihood of poor outcome. Taken together, our data suggests that CT psoas density measured during initial trauma evaluation can identify patients at greatest risk of poor outcomes.
We hypothesize that the significant differences found between our measures of sarcopenia are because they are capturing different aspects of this condition. Sarcopenia is defined not only as agerelated loss of skeletal muscle mass, but also loss of muscle strength and quality. Therefore, the psoas area, which many studies focus on as their sole measure of sarcopenia, may only be capturing the mass component, but not necessarily the functional component of this condition. Studies comparing muscle quantity to function support the premise that muscle mass differs from muscle quality. In a large-scale, prospective, longitudinal study comparing CT and dual-energy x-ray absorptiometry measurements of leg muscle mass against knee strength in a geriatric population, the researchers found that although loss of muscle quantity was associated with loss of strength, patients with preserved or even increased muscle mass had continued significant loss of strength, underscoring that muscle quantity does not necessarily measure muscle quality. 15 In a retrospective cohort study comparing CT-measured psoas density and area to assess severity of hypercortisolism and central sarcopenia, the researchers found that 24-hour cortisol levels had a more significant correlation with density than area, suggesting that density is capturing relevant morphometric information that area is not. 14 Evidence suggests that CT muscle density directly measures muscle quality and function. In a study comparing CT muscle density of the midthigh to muscle fiber adiposity and triglyceride content from percutaneous biopsy specimens of the vastus lateralis, researchers found that there was a significant negative correlation between density and lipid content showing that density is measuring fatty infiltration found in poorer quality Psoas density is a better predictor of poor outcomes than psoas area. (A) When the cohort is grouped into interquartile ranges by HUAC, those in the sarcopenia group (IQR1) have significantly increased probability of mortality (P = .008), duration of stay $7 days (P = .047), complication (P = .002), and dependent discharge (P = .03). Decreasing density from a higher quartile increases probability of poor outcome, indicating a density-dependent effect. (B) When the cohort is grouped into interquartile ranges by PI, those in the sarcopenia group (IQR1), have significantly increased probability of mortality only (P = .008). IQR1, 1stÀ25th percentile; IQR2, 26thÀ50th percentile; IQR3, 51stÀ75th percentile; IQR4, 76thÀ100th percentile. The asterisk (*) marks significance below a = .05. muscle. 15 Studies also have shown that greater CT muscle attenuation in the elderly is associated with increased muscle strength after adjustment for muscle area, indicating that muscle density may account for muscle strength differences that are not otherwise attributed to muscle quantity. 15 CT psoas muscle attenuation is not simply a function of advanced age. In a recent study looking at the effects of age on the CT muscle density of multifidus muscle groups in an otherwise well cohort, elderly patients (60 to 89 years) did have decreased psoas density compared with the youngest age group (20 to 39 years, 41.4 HU elderly group vs 43.2 HU young group), but this difference was not statistically significant. 16 The attenuation values are close to the average psoas density of our trauma cohort (43.3 HU). Furthermore, our cut-off value of sarcopenia (38.5 HU) is within the range calculated based on sensitivity analysis of mortality in a large cohort of patients undergoing elective gastrointestinal oncologic operation (38.1 to 39.9 HU). 10 Given the similar values in these studies compared with our own, we speculate that our cut-off value of sarcopenia is more widely generalizable.
Much of the literature regarding sarcopenia is meant for prognostication in the elective setting, with the goal of prehabilitating sarcopenic patients before operative insult to prevent morbidity and improve survival. 17 In contrast, we recognize that traumatic injury is a spontaneous event in which prehabilitation is not possible, which may decrease its utility in improving outcomes. Nevertheless, the preponderance of evidence suggests that specific physical and nutritional interventions in the immediate in-patient setting in elderly patients may improve their outcomes significantly and posthospitalization quality of life. It is well known that immobility and poor nutrition during hospitalization leads to significant decline in muscle function with resulting disability, especially in frail patients. 18, 19 Even after discharge, many patients fail to regain their previous level of function with standard nutrition and physical therapy regimens. 20 However, certain specific protein diet and resistance exercise regimens have been shown to preserve skeletal muscle mass and improve muscle function. 21, 22 Patients in the intensive care setting who have additional protein supplementation had reduced rates time on mechanical ventilation and mortality. 23, 24 Additional nutritional interventions, such as dietary supplementation have shown promise in combating sarcopenia. b-hydroxy-beta-methylbutyrate, an endogenous metabolite, has been demonstrated to decrease muscle catabolism and preserve muscle mass in geriatric patients without adverse effect. 25, 26 Interestingly, b-hydroxy-b-methylbutyrate has been shown to significantly decrease mortality when given to elderly patients in an acute, inpatient setting for acute exacerbations of chronic medical conditions, such as heart failure and chronic obstructive pulmonary disease. 27 Furthermore, there is evidence to suggest that frailty is in part, reversible with aggressive exercise and nutritional therapies. In a randomized control trial of elderly patients in a communal living facility, 6 months of exercise and nutritional interventions improved frailty scores, muscle strength, and gait speed, especially in patients undergoing both interventions. 21 Given the high proportion of falls as the mechanism of trauma in the elderly, we conjecture that identification of frail patients with objective CT-based measures may help identify patients that would benefit most from postdischarge, aggressive rehabilitation that may serve to prevent future secondary traumatic injury. 28 Our study has several noted limitations. Our data came from a cohort of 151 patients that were derived from a single institution in a single year, which may not reflect the patient population or outcomes at other centers and should be externally validated at other centers in a prospective fashion. The inclusion of all blunt mechanism of traumatic injury spans a wide spectrum of physiologic insult compared with other studies assessing outcomes after a more specific injury or surgical procedure. Some included patients may have received fluids, or in rare cases blood products which could contribute to edema and have an unknown impact on psoas muscle density. Lastly, our results were obtained in CT scans of the abdomen and pelvis with intravenous contrast measured during the venous phase. We chose this modality due to its use as the standard imaging modality in our institution for traumatic evaluation, as well as its overall broad use for multiple surgical indications. It is unknown how generalizable our results will be when considering other phase/noncontrast CT scans.
In our single-center retrospective cohort of patients who were evaluated in the trauma bay with blunt mechanism who received a CT scan of the abdomen/pelvis, psoas muscle density seems to be a good overall predictor of multiple clinically significant parameters. These include 90-day mortality, complication rate, duration of stay, and dependent discharge. Psoas density correlates with other markers of physiologic reserve including comorbidities, increased medication use, and advanced age and outperformed psoas area in these clinical parameters. Clinicians, dietitians, and therapists could use this tool to identify patients who would benefit from additional interventions to improve prognosis, aid in discharge planning, and prevent recurrent traumatic injury. Future studies will need to externally validate our findings, as well as determine if specific nutritional and physical therapy regimens can improve psoas density and decrease risk.
